Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enteric-coated cholestyramine capsule dose-finding crossover study in adults with short bowel syndrome
2018-004419-32Phase 2Terminated
- Sponsor
- Pharmascience
- Start
- Mar 2019
- Modality
- Small Molecules, Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of cholestyramine in bile acid diarrhea (BAD) and short bowel syndrome (SBS) (2 arms), sponsored by Pharmascience. Primary endpoint: Change in weekly frequency of bowel movements. Started Mar 2019; status: terminated.
02
Drugs
cholestyramine
03
Conditions
bile acid diarrhea (BAD)short bowel syndrome (SBS)
Beyond the preview
Go deeper on 2018-004419-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-004419-32.